In vivo lifetime and anti-cancer efficacy of doxorubicin-loaded nanogels composed of cinnamoyl poly (β-cyclodextrin) and cinnamoyl Pluronic F127

被引:11
|
作者
Yoon, Dong Youl
Kim, Jin-Chul [1 ]
机构
[1] Kangwon Natl Univ, Coll Biomed Sci, Dept Med Biomat Engn, Chunchon, South Korea
基金
新加坡国家研究基金会;
关键词
Rhodamine B isothiocyanate; cinnamoyl polymeric beta cyclodextrin; cinnamoyl Pluronic F127; nanogel; doxorubicin; in vivo lifetime; in vivo clearance; in vivo anticancer efficacy; ALGINATE;
D O I
10.1080/09205063.2017.1282401
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Nanogel composed of rhodamine B isothiocyanate-labeled cinnamoyl polymeric beta cyclodextrin and cinnamoyl Pluronic F127 was prepared by taking advantage of their self-assembling property in aqueous phase. The in vivo lifetime of the nanogel in the blood circulation system of hairless mouse was determined by fluorescence imaging method using rhodamine B isothiocyanate as a fluorescence probe, and it was more than 192 h. The in vivo clearance of doxorubicin loaded in the nanogel was observed by the same fluorescence imaging method. Doxorubicin loaded in the nanogel was cleared from the blood circulation system more slowly than free drug, indicating that the in vivo lifetime of the anti-cancer drug was prolonged by the nanogel. The fluorescence of doxorubicin was detected from the mouse even 200 h after the doxorubicin-loaded nanogel was intravenously injected into a mouse. According to the histological study of tumor tissue, the in vivo tumor growth-inhibiting efficacy of doxorubicin loaded in the nanogel was higher than that of free drug, possibly because of its longer in vivo lifetime.
引用
收藏
页码:505 / 518
页数:14
相关论文
共 9 条
  • [1] Nanogels Composed of Cinnamoyl Alginate and Cinnamoyl Pluronic F127
    Wang, Min Hui
    Kim, Jin-Chul
    JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2015, 36 (03) : 377 - 383
  • [2] Human growth hormone-loaded nanogels composed of cinnamoyl alginate, cinnamoyl Pluronic F127, and cinnamoyl poly(ethylene glycol)
    Lee, Ju Hyup
    Kim, Jin-Chul
    JOURNAL OF APPLIED POLYMER SCIENCE, 2015, 132 (34)
  • [3] In vivo residence duration of human growth hormone loaded in nanogels comprising cinnamoyl alginate, cinnamoyl Pluronic F127 and cinnamoyl poly(ethylene glycol)
    Yoon, Dong Youl
    Kim, Jin-Chul
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 509 (1-2) : 229 - 236
  • [4] Doxorubicin-containing microparticles comprising cinnamoyl gelatin-folic acid conjugate, cinnamoyl Pluronic F127, and cinnamoyl poly(β-cyclodextrin)
    Zhang, Hong
    Kim, Jin-Chul
    JOURNAL OF MACROMOLECULAR SCIENCE PART A-PURE AND APPLIED CHEMISTRY, 2017, 54 (06): : 394 - 401
  • [5] Thermo-triggerable self-assembly comprising cinnamoyl polymeric β cyclodextrin and cinnamoyl Pluronic F127
    Wang, Min Hui
    Jeong, Jae Hyun
    Kim, Jin-Chul
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 142 : 148 - 158
  • [6] Doxorubicin-loaded microgels composed of cinnamic acid-gelatin conjugate and cinnamic acid-Pluronic F127 conjugate
    Zhang, Hong
    Kim, Jin-Chul
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2016, 21 (03) : 296 - 301
  • [7] Doxorubicin loaded singlet-oxygen producible polymeric micelle based on chlorine e6 conjugated pluronic F127 for overcoming drug resistance in cancer
    Park, Hyung
    Park, Wooram
    Na, Kun
    BIOMATERIALS, 2014, 35 (27) : 7963 - 7969
  • [8] Enhanced anti-cancer efficacy to cancer cells by doxorubicin loaded water-soluble amino acid-modified β-cyclodextrin platinum complexes
    Zhao, Mei-Xia
    Zhao, Meng
    Zeng, Er-Zao
    Li, Yang
    Li, Jin-Ming
    Cao, Qian
    Tan, Cai-Ping
    Ji, Liang-Nian
    Mao, Zong-Wan
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2014, 137 : 31 - 39
  • [9] Enhanced antitumor efficacy by Paclitaxel-loaded Pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance
    Wei, Zhang
    Yuan, Shi
    Chen, Yanzuo
    Yu, Shuangyin
    Hao, Junguo
    Luo, Jieqi
    Sha, Xianyi
    Fang, Xiaoling
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 75 (03) : 341 - 353